PCYC
PCYC Articles
Source: courtesy of Pandora MediaMomentum stocks are the greatest things in the world when the market goes up like it did last year. There is always somebody willing to buy the stocks high under the...
Published:
Source: courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley taking a closer look at the top names. The firm initiated...
Published:
After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early March, especially in Celgene, Medivation and Pharmacyclics.
Published:
24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. By and large, short sellers shied away from these stocks in late January.
Published:
Baird offers an eclectic and interesting list for investors. A top regional firm, it tends to dig a little deeper, looking for ideas with not only growth potential, but catalysts. The usual big cap...
Published:
Source: Jon OggA new earnings season has started, and stocks and bonds are dealing with a likely patch for the government shutdown and the debt ceiling. So which are the stocks to buy and which the...
Published:
Source: Jon OggStocks have seen five days of selling, and investors are deciding which stocks are bargains and which ones will have more downside. 24/7 Wall St. reviews dozens of Wall Street analyst...
Published:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Thursday, July 18, 2013. They include Citrix Systems, eBay, Intel, SanDisk and Johnson &...
Published:
Source: ThinkstockPharmacyclics Inc. (NASDAQ: PCYC) has had a monster stock performance, with gains of much more than 200% over the past year. Now the company is doing what some shareholders will...
Published:
Source: Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the...
Published:
Source: ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary...
Published:
Last Updated:
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen so far this Tuesday. There is a larger concentration around biotech and emerging pharma this morning, but...
Published:
Last Updated:
Source: ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena...
Published:
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals...
Published:
Last Updated:
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from...
Published:
Last Updated: